Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Margalit

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Cancer Research and Clinical Oncology|June 2, 2022
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinomaOfer Margalit, Shun Yu, Einat Shacham-Shmueli, et al.
Melanoma Research|December 18, 2018
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanomaBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2022
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinomaOfer Margalit, Shun Yu, Einat Shacham-Shmueli, et al.
The Oncologist|January 31, 2019
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal AdenocarcinomaOfer Margalit, Ronac Mamtani, Scott Kopetz, et al.
Annals of Surgical Oncology|September 24, 2020
Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal CancerMohammad Adileh, Eyal Mor, Dan Assaf, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2022
Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical TrialLiat Hammer, David Hausner, Maoz Ben-Ayun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyDan Assaf, Eyal Mor, Shachar Laks, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
Annals of Surgical Oncology|July 7, 2021
Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with SurvivalEyal Mor, Dan Assaf, Shachar Laks, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cancer Research and Clinical Oncology|June 2, 2022
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinomaOfer Margalit, Shun Yu, Einat Shacham-Shmueli, et al.
Melanoma Research|December 18, 2018
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanomaBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2022
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinomaOfer Margalit, Shun Yu, Einat Shacham-Shmueli, et al.
The Oncologist|January 31, 2019
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal AdenocarcinomaOfer Margalit, Ronac Mamtani, Scott Kopetz, et al.
Annals of Surgical Oncology|September 24, 2020
Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal CancerMohammad Adileh, Eyal Mor, Dan Assaf, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2022
Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical TrialLiat Hammer, David Hausner, Maoz Ben-Ayun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyDan Assaf, Eyal Mor, Shachar Laks, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
Annals of Surgical Oncology|July 7, 2021
Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with SurvivalEyal Mor, Dan Assaf, Shachar Laks, et al.
Pageof 7